Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash Flow from Operating Activities
Net earnings (loss)	$ 46.6	$ (412.9)
Impairment charges	0.0	570.0
Depreciation and amortization	65.5	69.2
Share-based compensation expense	15.1	13.8
Loss on sale of assets	1.2	1.4
Gain on sale of Infant and Pet Care business	(4.1)	0.0
Deferred compensation payments	(8.7)	(7.3)
Deferred income taxes	(16.1)	(58.5)
Cost of early retirement of long-term debt	26.2	0.0
Other, net	7.3	(0.3)
Change in operating assets and liabilities	(14.4)	(77.2)
Net cash from operating activities	118.6	98.2
Cash Flow from Investing Activities
Capital expenditures	(26.9)	(38.7)
Proceeds from sale of Infant and Pet Care business	95.8	0.0
Proceeds from sale of assets	0.0	4.1
Collection of deferred purchase price on accounts receivable sold	3.9	9.0
Payments for other investing activities	(1.5)	(1.3)
Net Cash Provided by (Used in) Investing Activities, Total	71.3	(26.9)
Cash Flow from Financing Activities
Cash proceeds from the issuance of Senior Notes due 2028	750.0	0.0
Cash payments on Senior Notes due 2021	(600.0)	0.0
Cash proceeds from debt with original maturities greater than 90 days	50.0	316.0
Cash payments on debt with original maturities greater than 90 days	(167.0)	(198.0)
Repayment of Term Loan	0.0	(185.0)
Net increase in debt with original maturities of 90 days or less	1.7	5.7
Payments Of Debt Issuance Costs for Revolving Credit Facility	(3.6)	0.0
Debt issuance costs for Senior Notes due 2028	(10.4)	0.0
Cost of early debt retirement	(26.2)	0.0
Net financing (outflow) inflow from the Accounts Receivable Facility	(14.4)	5.6
Employee shares withheld for taxes	(1.7)	(1.8)
Net cash used by financing activities	(21.6)	(57.5)
Effect of exchange rate changes on cash	2.0	(1.2)
Cash and cash equivalents, beginning of period	341.6	266.4
Cash and cash equivalents, end of period	$ 511.9	$ 279.0